Topics, Categories, Guidelines
The submission period is now closed. Thank you to all who submitted.
Why Present at THT 2023?
- Attract international recognition.
- Elevate your professional and social media presence.
- Improve your competitiveness for scholarships and grants.
Submission Deadline
Monday, January 9, 2023, 2:00 PM EST (UTC −5)
Questions?
Email us at [email protected]
Submission Categories
Submit your abstracts of original research for the opportunity to present to thousands of your colleagues worldwide. Research can be in the form of clinical studies, basic science investigations, or preclinical studies and must be relevant to heart failure. Your abstracts must convey original research but can include portions of previous abstracts and/or manuscripts presented elsewhere.
If you have single-patient case report, please submit it as a challenging case, regardless of its novelty.
Opportunity to Submit to JACC: Heart Failure or Journal of Cardiac Failure (JCF)
THT will be collaborating with JACC: Heart Failure and Journal of Cardiac Failure (JCF) to create opportunities for authors of accepted abstracts to submit their work to be considered for publication. If your abstract is accepted for presentation at THT 2023, you may be invited to additionally submit as follows:
- JACC: Heart Failure, which is creating one dedicated issue highlighting innovations of structural interventions in heart failure. It will include state-of-the-art reviews, original research papers, and research letters.
- Journal of Cardiac Failure, which will select a limited number of THT abstracts to be published as state-of-the-art reviews, brief reports, or manuscripts throughout the year.
Guidelines
Character limit is 2,200, including spaces (approximately 300–350 words).
Submission Deadline
Monday, January 9, 2023, 2:00 PM EST (UTC −5)
Notification
Abstract submitters will be notified in mid-January.
Submit your most challenging heart failure management cases. Physicians at any career stage, including fellows, are encouraged to submit.
Guidelines
Character limit is 2,450 total for case summary, history, diagnostic tests, procedure, conclusion, comments. PowerPoint slide presentation highlighting your case is optional. Images: 10 MB. Video formats accepted: 30 MB mpeg, wmv, avi, mov, mpg, mp4.
Submission Deadline
Monday, January 9, 2023, 2:00 PM EST (UTC −5)
Notification
Challenging case submitters will be notified in mid-January.
Submit your late-breaking clinical science and first-in-human early feasibility studies. These are typically:
- Primary or important secondary endpoint results of prospective, randomized clinical trials.
- First-time presentations of first-in-human experiences with novel devices or drugs.
- Results of pilot studies of drugs or novel devices.
- Large-scale, impactful single/multicenter registries.
Accepted late-breaking science and first-in-human early feasibility studies are strictly embargoed until time of presentation.
Please note that the following rarely qualify as late-breaking clinical science submissions and, instead, should be submitted as abstracts: preclinical studies, early first-in-human device studies, and meta-analyses.
Opportunity to Submit to JACC: Heart Failure or Journal of Cardiac Failure (JCF)
THT will be collaborating with JACC: Heart Failure and Journal of Cardiac Failure (JCF) to create opportunities for authors of accepted late-breaking clinical science and first-in-human early feasibility studies to submit their work to be considered for publication. If your submission is accepted for presentation at THT 2023, you may be invited to additionally submit as follows:
- JACC: Heart Failure, which is creating one dedicated issue highlighting innovations of structural interventions in heart failure. It will include state-of-the-art reviews, original research papers, and research letters.
- Journal of Cardiac Failure, which will select a limited number of late-breaking clinical science and first-in-human early feasibility studies to be published as state-of-the-art reviews, brief reports, or manuscripts throughout the year.
Guidelines
Total character limit is 3,250, including spaces (primary endpoints: 550-character limit; secondary endpoints: 550-character limit; funding sources: 500-character limit). Upload .png or .jpg files only.
Submission Deadline
Monday, January 9, 2023, 2:00 PM EST (UTC −5)
Notification
Submitters will be notified in mid-January.
Enter the THT Shark Tank! Submit your concept-stage novel technologies in heart failure for a chance to present to a panel of expert judges. The THT Shark Tank Award winner will also receive $25,000 in consulting services provided by MCRA.
Your submission must be relevant to technology for the monitoring, diagnosis, or treatment of heart failure and address all the following:
- Unmet clinical need/field of use.
- Technology differentiation and competitive landscape.
- IP position/landscape.
- Summary of preclinical and/or first-in-human data.
- Regulatory pathway/strategy and commercialization strategy.
Opportunity to Submit to JACC: Basic to Translational Science (BTS)
Building on the success of last year’s Shark Tank issue of the publication, THT will be collaborating with JACC: Basic to Translational Science (BTS) for the second annual dedicated issue. If your submission is accepted for presentation at THT 2023, you will be invited to additionally submit a brief research letter for publication in the journal.
Guidelines
Describe clinical indication for innovative device or technology. Total character limit is 2,450, including spaces. Submit 15-20 PowerPoint slides covering aspects of the technology.
Submission Deadline
Monday, January 9, 2023, 2:00 PM EST (UTC −5)
Notification
Submitters will be notified in mid-January.
Submit clinical studies, basic science investigations, or preclinical studies relevant to some aspect of heart failure, including diagnosis, therapy, or monitoring. Case reports or case series may be submitted for consideration.
Top-rated submissions will be selected for oral presentation at a dedicated session for the competition finalists. Presentations will be evaluated by an expert panel that will select a winning abstract.
Eligibility
Current fellows, interns, residents, and medical students are eligible to submit an abstract for this competition. The submitter must have contributed substantially to the design and execution of the research, and this will be a major part of the grading.
Guidelines
Total character limit is 2,200, including spaces (approximately 300–350 words).
Submission Deadline
Monday, January 9, 2023, 2:00 PM EST (UTC −5)
Notification
Abstract submitters will be notified in mid-January.